Crystagen (Crystagen (Immune Peptide Bioregulator))
A short synthetic peptide bioregulator from the Khavinson family targeted at immune (thymus/lymphoid) tissue. It is used in the bioregulator community to support immune regulation and resilience, typically in short repeated courses.
How it works
As a signal peptide, it is proposed to enter cells and regulate gene expression in immune tissue, supporting normal thymic and lymphoid function, immune cell maturation, and balanced immune responses.
Key facts
- Molecular weight: ~ (short peptide)
- Half-life: Short (peptide)
- Bioavailability: Oral (encapsulated) or subcutaneous
- Storage: Room temperature (capsules) or refrigerate (injectable).
Dosing overview
- Typical dose: ~1-2 capsules/day or short injectable courses
- Frequency: Once daily
- Duration: 10-30 day courses
- Route: Oral capsule or subcutaneous
Protocol notes
- Taken as short repeatable courses (often 10-30 days), a few times per year.
- Oral encapsulated forms are taken once daily, usually on an empty stomach.
- Often cycled seasonally for immune support.
Reported benefits
- Immune regulation support
- Thymic/lymphoid tissue support (proposed)
- Immune resilience
- Short course-based protocol
- Part of bioregulator longevity systems
Possible side effects
- Limited Western clinical data
- Injection site reactions (injectable)
- Unknown long-term effects
Research
- Immune peptide bioregulators (2017): Reported to support thymic and lymphoid tissue function in regional research studies.
Compare Crystagen
Research and educational reference only. Not medical advice.